Sustainable weight loss,
supervised by physicians.

What this program treats

• Excess body weight (BMI ≥ 27 with comorbidities, or BMI ≥ 30)
• Stalled weight loss despite diet and exercise
• Insulin resistance and pre-diabetes
• Metabolic dysfunction associated with weight

What's included

• Comprehensive metabolic bloodwork (fasting glucose, HbA1c, lipids, liver, kidney)
• Video consultation with a licensed physician to review your labs and goals
• Personalized prescription of semaglutide or tirzepatide, dose-titrated to your response
• Monthly check-ins with your care team to monitor progress and side effects
• Quarterly bloodwork to track metabolic markers
• Direct messaging with your provider for questions between visits
• Medications shipped monthly to your door

The science

GLP-1 (glucagon-like peptide-1) receptor agonists were originally developed for type 2 diabetes management but have shown remarkable efficacy for weight reduction. They work by slowing gastric emptying, reducing appetite signals in the brain, and improving insulin sensitivity. Clinical trials have demonstrated average weight loss of 15-20% of body weight over 12-18 months when paired with lifestyle changes.

Who this is for

A good fit: Adults who have struggled to achieve sustained weight loss through lifestyle changes alone, who are looking for a medically supervised, evidence-based approach, and who are prepared to commit to monthly clinical follow-up.

Not the right fit: Patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, active pancreatitis, or pregnancy. Before prescribing, your physician will review your full medical history.